Dialyze Direct Signs Letter of Intent to Acquire Compass Home Dialysis
Summary
The proposed acquisition is also expected to achieve operating synergies and cost savings in the integration of the acquired business. “We are excited to partner with the industry leader in the SNF home dialysis market given their extensive hospital and payor relationships and their national scale.” The LOI sets out the principal terms on which the parties have agreed to complete the proposed transaction. Subject to customary approvals and confirmatory due diligence, the parties intend to enter into a definitive agreement with respect to the transaction on or before February 28, 2022. With a mission to build the next generation of kidney care, Dialyze Direct leverages its leading nephrology specialists to develop new methods and technology to evolve the treatment options nephrologists have at their disposal. Dialyze Direct’s innovative staff-assisted home hemodialysis treatment model entails a gentler, personalized treatment plan comprised of meticulously crafted protocols designed to tackle the unique fluid management challenges of geriatric dialysis patients, resulting in increased overall patient health and reduced hospitalizations while substantially decreasing costs for payors.